Bon Natural Life (BON) Common Equity (2020 - 2025)

Bon Natural Life (BON) has 6 years of Common Equity data on file, last reported at $57.6 million in Q3 2025.

• Quarterly Common Equity rose 31.07% year-over-year to $57.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $57.6 million (up 31.07% YoY) and the FY2025 annual result came in at $57.6 million, up 31.07% from the prior year.
• Common Equity improved to $57.6 million in Q3 2025 per BON's latest filing, from $43.9 million in the prior quarter.
• Across five years, Common Equity topped out at $57.6 million in Q3 2025 and bottomed at $14.0 million in Q1 2021.
• The 5-year median for Common Equity is $33.0 million (2022), against an average of $34.7 million.
• The widest annual swing landed in 2021, when Common Equity jumped 140.72%; it then climbed 13.41% in 2022.
• Tracing BON's Common Equity over 5 years: stood at $26.5 million in 2021, then gained by 13.41% to $30.1 million in 2022, then gained by 19.57% to $36.0 million in 2023, then climbed by 22.02% to $43.9 million in 2024, then soared by 31.07% to $57.6 million in 2025.
• Per Business Quant, the three latest BON Common Equity figures stand at $57.6 million (Q3 2025), $43.9 million (Q3 2024), and $36.0 million (Q3 2023).

Peer Comparison